comparative effectiveness of semaglutide and tirzepatide vs bariatric surgery Efficacy for weight loss it's to weight loss in inflammatory bowel disease | Indian Journal of Gastroenterology Tirzepatide vs. Semaglutide: What's the

The World Health Organisation's 2026 global guidelines on GLP-1 therapies for obesity explicitly recommend combining medication with intensive behavioural interventions, including structured goal-setting for diet and physical activity

The Cravings Battler: Those fighting a daily battle against uncontrollable cravings, overeating, and endless hunger cues

Understanding how these medications interact with your digestive system helps you make informed decisions about your weight loss journey

Timing and severity vary significantly based on dose, individual metabolism, GI sensitivity, and genetic factors affecting GLP-1 receptor function

Headline results from OASIS 1 - a phase 3a 68-week, efficacy and safety trial comparing once-daily oral semaglutide 50 mg for weight management to placebo in 667 adults with obesity or overweight with one or more comorbidities have revealed the trial achieved its primary endpoint by demonstrating a statistically significant and superior weight loss at week 68 with oral semaglutide 50mg versus placebo.When evaluating the effects of treatment if all people adhered to treatment from a mean baseli

Is this really the holy grail of body composition?